Harbor Healthcare Consultants News

Harbor Healthcare Announces The Sale Of A Nevada Behavioral Health LTC Pharmacy

Nevada – Harbor Healthcare Consultants proudly announces the successful sale of a specialized behavioral health focused long-term care pharmacy with multiple locations throughout the state. Acting as the Exclusive Sell-Side Advisor, Harbor Healthcare facilitated this strategic acquisition by a private equity-backed company, marking their first and meaningful expansion into Nevada’s behavioral health sector. This transaction […]

More

Harbor Healthcare Announces The Sale Of IV Services Infusion Pharmacy

Harbor Healthcare Consultants, a leading mergers and acquisitions advisory firm specializing in pharmacy transactions, is pleased to announce the successful sale of one of IV Services to Genefic, a premier provider of comprehensive infusion and specialty pharmacy services. The transaction represents a strategic move for both parties. IV Services, a respected provider of infusion therapies, […]

More

Harbor Healthcare Announces The Sale Of The Compounding Center

Harbor Healthcare Consultants, a leading pharmacy mergers and acquisitions advisory firm founded by pharmacist Ira Cammeyer, is pleased to announce the successful sale of a premier 503A compounding pharmacy accredited for sterile and non-sterile formulations. Licensed in 12 states across the mid-Atlantic, The Compounding Center, originally established in 1976, built an exceptional reputation for quality […]

More

Harbor Healthcare Announces The Successful Sale Of A California Specialty Infusion Pharmacy

Southern California | 2024 Harbor Healthcare Consultants is pleased to announce the successful sale of a premier specialty infusion pharmacy and home healthcare business, headquartered in Southern California, to a leading nationwide pharmacy services company. Harbor Healthcare Consultants served as the exclusive sell-side advisor for the transaction. The seller, a well-respected pharmacy provider has established […]

More

Harbor Healthcare Advises Behavioral Health LTC Pharmacy On Its Sale

Eastern USA • April 2024 Harbor Healthcare Consultants, a leading healthcare advisory firm, is pleased to announce the successful completion of the acquisition of a dual-location long-term care (“LTC”) pharmacy focused on behavioral health by a leading private equity-backed strategic acquirer. The acquisition, facilitated by Harbor Healthcare, spans operations across two eastern US states and […]

More

Harbor Healthcare Advises American Integrative Compounding Pharmacy On Its Sale

Los Angeles, CA – 2024 – American Integrative Pharmacy, a distinguished 503A Compounding Pharmacy based in Los Angeles, California, and specializing in mental health, hormones, and women’s health, officially announced its acquisition by a nationwide pharmacy. The strategic purchase further accelerates the acquirer’s continued growth and expansion in the 503A compounding industry. Harbor Healthcare Consultants […]

More

Harbor Healthcare Announces the Successful Sale of California’s Largest Independent Behavioral Health Pharmacy

California, 2023 – Harbor Healthcare Consultants, a leading M&A advisory firm specializing in healthcare and pharmacy transactions, proudly announces the successful sale of California’s largest independent behavioral health pharmacy services company, to a leading Private Equity acquirer with extensive experience and expertise in the healthcare space. This milestone transaction reflects the culmination of strategic efforts […]

More

2023 Compounding Pharmacy M&A Market Update – How USP 800, Semaglutide And Competitive Forces Will Shape The Industry

This year is a dynamic and fast-paced one for compounding pharmacy M&A. Early in the year, unpredictability in the broader economy created challenges for transactions and Semaglutide created a boom for sellers. but pause for buyers. However, as the year progressed, anxiety dissipated, and buyers resumed their acquisition mandates. Last but not least, the constant […]

More

Harbor Healthcare Advises La Vita Compounding On Its Sale & Strategic Partnership

San Diego, November 2023 – La Vita Compounding Pharmacy, a trusted 503A compounding pharmacy, is proud to announce its acquisition by a strategic buyer. The acquisition comes as part of the buyer’s strategic vision to build a national platform in the compounding pharmacy industry, leveraging the expertise and reputation of La Vita as they expand […]

More

2023 LTC Pharmacy Market Update – How Inflation and Marginalized Patients Will Impact Values in The Coming Years

LTC Pharmacy underwent more disruption and change in just the past few years than the preceding decades. Revenue models morphed, strategies reversed, and service transformed. The M&A landscape is now replete with both private equity-backed and independent operators scooping up quality businesses. At the same time, LTC facility M&A is speeding up after a slow […]

More